For most of the last few decades, the billing sequence in American healthcare was predictable. You received care, the provider billed your insurer, the insurer paid its share, and then you got a bill for whatever was left. That order is changing. A growing number of...

Health insurers file proposed rates with state regulators every year, and those filings are the earliest reliable signal of what employers will pay when their plans renew. The 2027 filings are in, and the picture for small businesses is not a comfortable one. Across...

The Affordable Care Act Marketplaces are undergoing significant shifts that are reshaping the landscape for millions of enrollees. Recent developments paint a complex picture of rising costs, enrollment losses, and a fundamental transformation in how people access...

Alternative health plan designs are moving from niche to mainstream. For decades, employers managed healthcare costs with the same tools: higher deductibles, narrower networks, and increased cost sharing. A more meaningful shift is now gaining momentum. According to...

Commercial healthcare costs are on track to rise 9% in 2027, according to a new analysis from PwC. That would be the highest medical cost trend in nearly two decades. The individual market is projected to increase 8.5%. PwC also revised its 2026 estimates upward,...

Novo Nordisk launched an oral version of its weight loss drug Wegovy on January 5, 2026, and the numbers since then have been hard to ignore. In roughly five months, the pill crossed 3 million prescriptions in the U.S., a pace the company describes as one of the...

Karleigh McClain did everything she thought she was supposed to do. She researched her options, signed up with a reputable-seeming telehealth company, met virtually with a provider, and started a weight loss medication that had helped her lose 50 pounds just a few...

For the first time in its history, Medicare is preparing to cover weight loss drugs at scale. Beginning July 1, 2026, the new Medicare GLP-1 Bridge will give eligible Part D beneficiaries access to medications like Wegovy, Zepbound, and the newly approved Foundayo for...

The Centers for Medicare and Medicaid Services refreshed its Overall Hospital Quality Star Rating this week, and the new numbers tell a familiar story. Most American hospitals are clustered in the middle of the distribution, with a small group of standouts at the top,...

https://www.youtube.com/watch?v=WQDsMje-WPE Medicare is about to do something it has never done before: cover prescription weight loss drugs. Starting July 1, 2026, eligible Medicare beneficiaries can get Wegovy, Zepbound, or Foundayo for just $50 a month through a...